We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Just as Stryker is in the midst of a corporatewide overhaul of its quality systems resulting from two GMP-related warning letters and a recall and temporary production stoppage of its implantable hip cups, the FDA has cited the firm in yet another warning letter.